title: Unusual late development of dopamine agonist resistance in two women with hyperprolactinaemia associated with transition from micro to macroadenoma.
authors.forename: D
authors.initials: D
authors.lastname: McCall
authors.forename: S J
authors.initials: SJ
authors.lastname: Hunter
authors.forename: R S
authors.initials: RS
authors.lastname: Cooke
authors.forename: B
authors.initials: B
authors.lastname: Herron
authors.forename: B
authors.initials: B
authors.lastname: Sheridan
authors.forename: A B
authors.initials: AB
authors.lastname: Atkinson
mesh_terms: D000328:Adult; D000077465:Cabergoline; D018450:Disease Progression; D018491:Dopamine Agonists / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D015175:Prolactinoma / Q000150:complications / Q000188:drug therapy* / Q000473:pathology
chemical_list: D018491:Dopamine Agonists; D004873:Ergolines; D000077465:Cabergoline